{"name": "Shield Therapeutics",
 "permalink": "shield-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/shield-therapeutics",
 "homepage_url": "http://www.shieldtherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@shieldtherapeutics.com",
 "phone_number": "+44 (0)1932 268436",
 "description": "",
 "created_at": "Thu Jun 02 03:36:54 UTC 2011",
 "updated_at": "Thu Jun 02 03:36:52 UTC 2011",
 "overview": "\u003Cp\u003EShield Therapeutics, founded in 2008, is an independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need. During 2011 Shield will be commencing global pivotal Phase III studies of its lead asset, ST10-021, for the treatment of iron deficiency anaemia associated with inflammatory bowel disease and subsequently chronic kidney disease. The Company is headquartered in Wollerau, Switzerland.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       63],
      "assets/images/resized/0013/7404/137404v1-max-150x150.png"],
     [[250,
       105],
      "assets/images/resized/0013/7404/137404v1-max-250x250.png"],
     [[261,
       110],
      "assets/images/resized/0013/7404/137404v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Carl",
      "last_name": "Sterritt",
      "permalink": "carl-sterritt",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Richard",
      "last_name": "Jones",
      "permalink": "richard-jones-9",
      "image": null}},
   {"is_past": false,
    "title": "CMO",
    "person":
     {"first_name": "Christian",
      "last_name": "Schweiger",
      "permalink": "christian-schweiger",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac8.2M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.shieldtherapeutics.com/news.asp?id=9",
    "source_description": "Shield Therapeutics Raises 8.2 million",
    "raised_amount": 8200000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2011,
    "funded_month": 6,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Inventages Venture Capital Investment Inc.",
         "permalink": "inventages-venture-capital-investment-inc",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0396/50396v1-max-150x150.png"],
             [[208,
               59],
              "assets/images/resized/0005/0396/50396v1-max-250x250.png"],
             [[208,
               59],
              "assets/images/resized/0005/0396/50396v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Abbey House",
    "address2": "Wellington Way",
    "zip_code": "KT13 0TT",
    "city": "Weybridge ",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null},
   {"description": "",
    "address1": "Sihleggstrasse 23",
    "address2": "",
    "zip_code": "8832 ",
    "city": "Wollerau",
    "state_code": null,
    "country_code": "CHE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}